Nassim Usman, Director at GYRE THERAPEUTICS, INC. (GYRE), sold 20,000 shares at $14.90 ($283K) on 2024-05-01, disclosed to the SEC on 2024-05-02.
Scheduled sale ($283k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.86 | 14,900 | $207K | 73.1% |
| 2 | $14.90 | 5,000 | $75K | 26.4% |
| 3 | $15.63 | 100 | $2K | 0.6% |
| Total | $14.13 avg | 20,000 | $283K | 100% |
| Filing → |
| GYRE | SELL | 2024-03-19 | $690K | — | Filing → |
| CBIO | BUY | 2022-08-10 | $2K | — | Filing → |
| CBIO | BUY | 2022-02-16 | $1K | — | Filing → |